This edition of CIM Seminar series - "Immune endotypes and host-directed therapies in tuberculosis (TB)" has already taken place.

Search future editions →

Events Healthcare & MedTech

Healthcare & MedTech

CIM Seminar series - "Immune endotypes and host-directed therapies in tuberculosis (TB)" 2026

Trade-orientedBoutiqueIn-personLocal draw
📅 11 June 2026 📍 Aula Medica, Stockholm, SE ↗ 🏢 Karolinska Institutet

A Center for Infectious Medicine (CIM) seminar at Karolinska Institutet focusing on TB immunopathogenesis, host-directed therapies, and patient stratification.

Attendees: Researchers, clinicians, and academic professionals in immunology and infectious diseases.

Planning for next year?

A curated group of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.

Request intelligence →

Delivery within 24 hours · $1,250

Venue

Aula Medica

Convention centre · 1 halls · ~1,000 people

A triangular building on Campus Solna, Stockholm, housing a 1,000-seat amphitheater-style auditorium (Erling Persson Hall), conference spaces, and restaurants. Completed in 2013, it hosts Nobel lectures, scientific symposia, and international conferences.

📍 Nobels väg 6, 171 65 Solna, Sweden

Operated by Akademiska Hus

102 events tracked at this venue → Venue website ↗

Organizer

Karolinska Institutet - StratNeuro

Government · Stockholm, Sweden · Founded 1810

The Strategic Research Area Neuroscience at Karolinska Institutet focuses on translational brain research.

Runs 34 events →

Why people attend

Academic researchers, clinicians, and biotech professionals attending to learn about new TB treatment strategies and immune endotyping.

Exhibitor categories

Academic ResearchClinical ImmunologyInfectious Disease

Sample matches

Filtered to a Series-B SaaS ICP. Your filter will be different.

Sample Match A

example.com

91 — High
Enterprise SaaS200–500 employeesAmsterdam, NL

"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."

Sample Match B

example.io

79 — Medium
Cloud platform50–200 employeesLondon, UK

"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."

████████ ██████

████████.io

██ — Medium
████████████ 200–500 employees ████, ██

"████████████████████████████████████████."

Submit your ICP
to unlock all matches

Request intelligence →

████████ ██████

████████.io

██ — Medium
████████████ 200–500 employees ████, ██

"████████████████████████████████████████."

Submit your ICP
to unlock all matches

Request intelligence →

More Healthcare & MedTech events

Healthcare & MedTech

Pharma Manufacturing World Summit

Boston, US May 2027

Healthcare & MedTech

REHAB

Karlsruhe, DE May 2027

400 exhibitors

Healthcare & MedTech

Vitafoods Europe

Barcelona, ES May 2027

1,600 exhibitors

Healthcare & MedTech

World Vaccine Congress Washington

Washington D.C., US Mar 2027

More Healthcare & MedTech events

All Healthcare & MedTech trade showsAll events in Sweden

Frequently asked questions

When is CIM Seminar series - "Immune endotypes and host-directed therapies in tuberculosis (TB)"?+
CIM Seminar series - "Immune endotypes and host-directed therapies in tuberculosis (TB)" takes place on 11 June 2026.
Where is CIM Seminar series - "Immune endotypes and host-directed therapies in tuberculosis (TB)" held?+
CIM Seminar series - "Immune endotypes and host-directed therapies in tuberculosis (TB)" is held at Aula Medica, Stockholm, SE.
Who organises CIM Seminar series - "Immune endotypes and host-directed therapies in tuberculosis (TB)"?+
CIM Seminar series - "Immune endotypes and host-directed therapies in tuberculosis (TB)" is organised by Karolinska Institutet.

Ready to map CIM Seminar series - "Immune endotypes and host-directed therapies in tuberculosis (TB)"?

Request intelligence →